Jennifer Coleman

858 total citations
19 papers, 677 citations indexed

About

Jennifer Coleman is a scholar working on Genetics, Epidemiology and Oncology. According to data from OpenAlex, Jennifer Coleman has authored 19 papers receiving a total of 677 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 10 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in Jennifer Coleman's work include Virus-based gene therapy research (13 papers), Herpesvirus Infections and Treatments (10 papers) and CAR-T cell therapy research (6 papers). Jennifer Coleman is often cited by papers focused on Virus-based gene therapy research (13 papers), Herpesvirus Infections and Treatments (10 papers) and CAR-T cell therapy research (6 papers). Jennifer Coleman collaborates with scholars based in United States, Australia and Italy. Jennifer Coleman's co-authors include James M. Markert, G. Yancey Gillespie, Jacqueline N. Parker, Kevin A. Cassady, Richard J. Whitley, Cheryl A. Palmer, Alfred D. Lakeman, James J. Cody, Shantanu N. Razdan and Matthias Karrasch and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Journal of Virology.

In The Last Decade

Jennifer Coleman

19 papers receiving 669 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Coleman United States 11 447 405 266 173 140 19 677
Jayson Hardcastle United States 10 572 1.3× 475 1.2× 353 1.3× 165 1.0× 237 1.7× 11 853
Luke Russell United States 11 370 0.8× 329 0.8× 294 1.1× 97 0.6× 172 1.2× 19 648
R L Martuza United States 12 704 1.6× 377 0.9× 436 1.6× 343 2.0× 163 1.2× 13 916
E. Galanis United States 9 430 1.0× 289 0.7× 340 1.3× 104 0.6× 32 0.2× 17 656
Jacqueline Kintz France 11 429 1.0× 252 0.6× 331 1.2× 70 0.4× 118 0.8× 11 618
Michael Ehrhardt United States 13 166 0.4× 175 0.4× 211 0.8× 44 0.3× 295 2.1× 20 702
Felix G. Hermann Germany 12 252 0.6× 151 0.4× 349 1.3× 50 0.3× 119 0.8× 16 621
Cecilia Barese United States 13 149 0.3× 383 0.9× 178 0.7× 81 0.5× 381 2.7× 25 674
Jason Debasitis United States 3 129 0.3× 125 0.3× 286 1.1× 54 0.3× 110 0.8× 3 458
Christopher R. Logg United States 19 543 1.2× 273 0.7× 630 2.4× 73 0.4× 82 0.6× 27 886

Countries citing papers authored by Jennifer Coleman

Since Specialization
Citations

This map shows the geographic impact of Jennifer Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Coleman more than expected).

Fields of papers citing papers by Jennifer Coleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Coleman. The network helps show where Jennifer Coleman may publish in the future.

Co-authorship network of co-authors of Jennifer Coleman

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Coleman. A scholar is included among the top collaborators of Jennifer Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Coleman. Jennifer Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Manuel, Justin, Hongtao Gu, Xue‐Zhong Ma, et al.. (2023). 338.1: Islet isolation after normothermic ex vivo machine perfusion of 2 discarded human pancreas allografts: A proof of concept study. Transplantation. 107(10S2). 145–146. 1 indexed citations
2.
Kasten, Benjamin B., Hailey Houson, Jennifer Coleman, et al.. (2021). Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model. Scientific Reports. 11(1). 15384–15384. 19 indexed citations
3.
Jokubaitis, Vilija, Jim Stankovich, Josephine Baker, et al.. (2021). High rates of JCV seroconversion in a large international cohort of natalizumab-treated patients. Therapeutic Advances in Neurological Disorders. 14. 1280220483–1280220483. 9 indexed citations
4.
Dhakal, Hari Prasad, Jennifer Coleman, & Christopher G. Przybycin. (2019). A Novel Dual Immunostain to Characterize Sloughed Cells in Testicular Biopsies for Infertility. The American Journal of Surgical Pathology. 43(8). 1123–1128. 3 indexed citations
5.
Cassady, Kevin A., Katherine E. Miller, Nripesh Prasad, et al.. (2019). ATIM-32. PREDICTORS OF IMPROVED SURVIVAL FOLLOWING ONCOLYTIC VIRUS TREATMENT IN PATIENTS WITH RECURRENT GLIOBLASTOMA: GENE EXPRESSION ANALYSIS FROM THE PHASE IB G207 CLINICAL TRIAL. Neuro-Oncology. 21(Supplement_6). vi8–vi8. 1 indexed citations
6.
Ghonime, Mohammed G., Amish C. Shah, Justin C. Roth, et al.. (2017). Chimeric HCMV/HSV-1 and Δγ134.5 oncolytic herpes simplex virus elicit immune mediated antigliomal effect and antitumor memory. Translational Oncology. 11(1). 86–93. 28 indexed citations
7.
Cassady, Kevin A., David F. Bauer, Justin C. Roth, et al.. (2017). Pre-clinical Assessment of C134, a Chimeric Oncolytic Herpes Simplex Virus, in Mice and Non-human Primates. Molecular Therapy — Oncolytics. 5. 1–10. 43 indexed citations
8.
Waters, Alicia M., Jerry E. Stewart, Gregory K. Friedman, et al.. (2016). Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma. Translational Oncology. 9(5). 419–430. 8 indexed citations
9.
10.
Roth, Justin C., Kevin A. Cassady, James J. Cody, et al.. (2014). Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates. 776275620–776275620. 3 indexed citations
11.
12.
Roth, Justin C., Jennifer Coleman, Richard J. Whitley, et al.. (2014). Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines. Gene Therapy. 21(11). 984–990. 18 indexed citations
13.
Stewart, Jerry E., Elizabeth Mroczek‐Musulman, Alicia M. Waters, et al.. (2014). Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors. PLoS ONE. 9(1). e86843–e86843. 15 indexed citations
14.
Markert, James M., Shantanu N. Razdan, Hui‐Chien Kuo, et al.. (2014). A Phase 1 Trial of Oncolytic HSV-1, G207, Given in Combination With Radiation for Recurrent GBM Demonstrates Safety and Radiographic Responses. Molecular Therapy. 22(5). 1048–1055. 240 indexed citations
15.
Stewart, Jerry E., Elizabeth Mroczek‐Musulman, Alicia M. Waters, et al.. (2013). Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma. PLoS ONE. 8(10). e77753–e77753. 26 indexed citations
16.
Markert, James M., James J. Cody, Jacqueline N. Parker, et al.. (2012). Preclinical Evaluation of a Genetically Engineered Herpes Simplex Virus Expressing Interleukin-12. Journal of Virology. 86(9). 5304–5313. 60 indexed citations
17.
Lin, Wei‐Jye, Jun Tsao, Xiaolin Zhu, et al.. (2011). Posttranscriptional Control of Type I Interferon Genes by KSRP in the Innate Immune Response against Viral Infection. Molecular and Cellular Biology. 31(16). 3196–3207. 72 indexed citations
18.
Friedman, Gregory K., Catherine P. Langford, Jennifer Coleman, et al.. (2009). Engineered herpes simplex viruses efficiently infect and kill CD133+ human glioma xenograft cells that express CD111. Journal of Neuro-Oncology. 95(2). 199–209. 66 indexed citations
19.
Macdonell, Richard, et al.. (2002). Treatment of multiple sclerosis with newer immune-modulating drugs. Australian Prescriber. 25(2). 32–35. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jayson Hardcastle Breakdown of academic impact, for papers by Luke Russell Breakdown of academic impact, for papers by R L Martuza Breakdown of academic impact, for papers by E. Galanis Breakdown of academic impact, for papers by Jacqueline Kintz Breakdown of academic impact, for papers by Michael Ehrhardt Breakdown of academic impact, for papers by Felix G. Hermann Breakdown of academic impact, for papers by Cecilia Barese Breakdown of academic impact, for papers by Jason Debasitis Breakdown of academic impact, for papers by Christopher R. Logg
Rankless by CCL
2026